Innovation
3 patent families (3 granted) — focus: Human necessities; filing pace accelerating. Cited 1,213 times.
| Year | Filings |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Social engagement
Social engagement: 1.7K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
8 investors on record; lead investors include Medical Research Commercialisation Fund, Tenmile, Brandon BioCatalyst.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 88% |
| Other / undisclosed | 1 | 13% |
Recent activity
1 May 2026
Event
BioCentury Inc. EBD Group 26th
8 Apr 2026
Leadership hire
Board of Directors
11 Mar 2026
Event
BioEurope Spring Informa Connect EBD Group and LSX World Congress Europe